JUN 05, 2019 12:00 PM PDT

Use of Functional Inhibitors of Acid Sphingomyelinase (FIASMA) to Treat Intracelluar Bacterial Infections

WRITTEN BY: Dena Aruta

Researchers at Virginia Commonwealth University presented the findings of their study published in Life Science Alliance that certain antidepressants may have the potential to treat infections with intracellular microorganisms. These drugs, known as functional inhibitors of acid sphingomyelinase (FIASMAs), interfere with acid sphingomyelinase (ASM), an enzyme that aids in the release of LDL cholesterol from the lysosome. The activity of ASM is an integral part of the infectious process with intracellular microorganisms because they target cholesterol within the cells. The FIASMAs analyzed in this study were desipramine, amitriptyline, and nortriptyline, which belong to the drug class, tricyclic antidepressants.

"Since FIASMAs influence cholesterol trafficking in the cell and cholesterol plays a role in so many facets of our biology, they have been used to treat a wide variety of conditions and diseases," Carlyon said.

Anaplasma phagocytophilum, Coxiella burnetii, Chlamydia trachomatis, and Chlamydia pneumoniae were used to demonstrate that the activity of ASM is a vital part of the infectious process. The four organisms are "obligate intracellular vacuole-adapted bacterial pathogens that target host cholesterol trafficking pathways" and are responsible for the diseases human granulocytic anaplasmosis, Q fever, pneumonia, and a sexually transmitted infection. 

The findings of the study demonstrated that ASM inhibition was more effective with desipramine when testing  A.phagocytophilum and C. burnetii than the other two organisms. Desipramine was less effective with C. pneumoniae since it uses sources of both LDL cholesterol and non-LDL cholesterol during its growth cycle. C. trachomatis showed even less inhibition than C. pneumoniae. 

"It would be highly beneficial to have a class of drugs to treat such diseases in patients for whom tetracyclines are contraindicated," Carlyon said. "These drugs could provide an alternative to antibiotics or even be used in conjunction with them as an augmentation approach to treat infections that typically require prolonged courses of antibiotic therapy, such as those caused by Chlamydia pneumoniae and Coxiella burnetii."

Carlyon went on to state that: "What is so exciting about this study is that the class of drugs we evaluated targets an enzyme in our cells regulating cholesterol, not the bacteria," Carlyon said. "I do not envision the pathogens being able to develop resistance to this treatment because it is targeting a host pathway that they very much need to grow and survive inside of the body."

The researchers suggest that, since these drugs are likely to prevent resistance, they should be evaluated clinically as an alternative to antibiotics or in conjunction with one to augment their efficacy. 

About the Author
  • After earning my Bachelor of Science degree in biology/chemistry from Virginia Polytechnic Institute and State University (aka Va. Tech), I went on to complete clinical rotations in laboratory medicine at Roanoke Memorial Hospital. I spent the next 21 years working in healthcare as a clinical microbiologist. In 2015, I combined my fascination with medicine and passion for writing into a freelance career, and I haven't looked back. Even though my expertise is in microbiology and infectious diseases, I'm adept at writing about any medical topic. Being a freelance writer allows me to pursue a career where I can work at home with my two feline assistants, Luke and Grace. I'm a firm supporter of animal rights and volunteer for a local rescue during my free time. 
You May Also Like
DEC 13, 2019
Technology
DEC 13, 2019
Can Virtual Reality Advance Art Therapy?
Virtual reality (VR) has been a rapidly expanding field with a broad spectrum of applications in health care and medicine. Recent studies have examined if...
DEC 13, 2019
Health & Medicine
DEC 13, 2019
Rise of Cannabis Use Disorder Due to Legalization?
The topic of cannabis use disorder is growing as marijuana becomes more commonly and openly used by the general public. In the past, research has been conf...
DEC 13, 2019
Genetics & Genomics
DEC 13, 2019
22 Genes Discovered that Predict Skin Cancer from Sun Exposure
Australia has the highest rate of skin cancer in the world, with around 49 cases per 100,000 people. Now, researchers at the QIMR Berghofer Medical Researc...
DEC 13, 2019
Cell & Molecular Biology
DEC 13, 2019
A Critical Step in Ribosome Assembly is Viewed For the First Time
Proteins are critical to biology, and are generated by vital, ancient cellular structures called ribosomes....
DEC 13, 2019
Genetics & Genomics
DEC 13, 2019
Neurotoxin Cadmium and Gene Combo Accelerates Cognitive Decline
Findings from a new animal study suggest that exposure to cadmium, a neurotoxin, leads to accelerated cognitive impairment. Males with a genetic risk facto...
DEC 13, 2019
Technology
DEC 13, 2019
An App Can Help Fight Drug Addiction Relapse
A computer game, on the verge of becoming a smartphone app, can use math to detect a patient’s comfort with risk-taking. Specifically, the game is ba...
Loading Comments...